Denali Therapeutics Inc. · NASDAQ:DNLI

T. Rowe Price Investment Management, Inc. reported a 10.20% stake in Denali Therapeutics Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 8, 2026

T. Rowe Price Investment Management, Inc. reported a 10.20% stake in Denali Therapeutics Inc., 16,178,963 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).

Stake
10.20%
Shares
16,178,963
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.10.20%16,178,963

Source

View original at SEC

Related